SEARCH

SEARCH BY CITATION

References

  • 1
    Von Euler US & Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol (Lond) 1931; 72: 7487.
  • 2
    Pernow B. Studies on substance P purification, occurrence, and biological actions. Acta Physiol Scand 1953; 29: 190.
  • 3
    Ehrenpreis T & Pernow B. On the occurrence of substance P in the rectosigmoid in Hirschsprung's disease. Acta Physiol Scand 1952; 27: 380.
  • 4
    Lembeck F. Zur Frage der zentralen Übertragung afferenter Impulse III. Mitteilung. Das Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des Rückenmarks. Naunyn-Schmiedeberg's Arch Pharmacol 1953; 219: 197213.
  • 5
    Chang MM, Leeman SE & Niall HD. Amino acid sequence of substance P. Nature (New Biol) 1971; 232: 867.
  • 6
    Tregear GW, Niall HD, Potts JT, Leeman SE & Chang MM. Synthesis of substance P. Nature (New Biol) 1971; 232: 879.
  • 7
    Powell D, Leeman SE, Tregear GW, Niall HD & Potts JJT. Radioimmunoassay for substance P. Nature (New Biol) 1973; 241: 2524.
  • 8
    Takahashi T, Konishi S, Powell D, Leeman SE & Otsuka M. Identification of the motoneuron-depolarizing peptide in bovine dorsal root as hypothalamic substance P. Brain Res 1974; 73: 5969.
  • 9
    Henry JL. Effects of substance P on functionally identified units in cat spinal cord. Brain Res 1976; 114: 43951.
  • 10
    Takahashi T & Otsuka M. Regional distribution of substance P in the spinal cord and nerve roots of the cat and the effect of dorsal root section. Brain Res 1975; 87: 111.
  • 11
    Hökfelt T, Kellerth JO, Nilsson G & Pernow B. Substance P localization in the central nervous system and in some primary sensory neurons. Science 1975; 190: 88990.
  • 12
    Nilsson G, Larsson LT, Håkanson R, Brodin E, Pernow B & Sundler F. Localization of substance P-like immunoreactivity in mouse gut. Histochemistry 1975; 43: 979.
  • 13
    Cuello AC & Kanazawa I. The distribution of substance P immunoreactive fibers in the rat central nervous system. J Comp Neurol 1978; 178: 12956.
  • 14
    Ljungdahl Å , Hökfelt T & Nilsson G. Distribution of substance P-like immunoreactivity in the central nervous system of the rat I. Cell bodies and nerve terminals. Neurosci 1978; 3: 861943.
  • 15
    Schultzberg M, Hökfelt T & Nilsson G et al. Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β-hydroxylase. Neurosci 1980; 5: 689744.
  • 16
    Costa N, Cuello AC, Furness JB & Franco R. Distribution of enteric neurons showing immunoreactivity for substance P in the guinea-pig ileum. Neurosci 1980; 5: 32331.
  • 17
    Otsuka M & Konishi S. Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. Nature 1976; 264: 834.
  • 18
    Olgart L, Gazelius B, Brodin E & Nilsson G. Release of substance P-like immunoreactivity from the dental pulp. Acta Physiol Scand 1977; 101: 5102.
  • 19
    Otsuka M & Takahashi T. Putative peptide neurotransmitters. Ann Rev Pharmacol Toxicol 1977; 17: 42539.
  • 20
    Nicoll RA, Schenker C & Leeman SE. Substance P as a neurotransmitter candidate. Annu Rev Neurosci 1980; 3: 22768.
  • 21
    Pernow B. Substance P. Pharmacol Rev 1983; 35: 84141.
  • 22
    Otsuka M & Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993; 73: 229308.
  • 23
    Nakanishi S. Substance P precursor and kininogen: their structures, gene organizations, and regulation. Physiol Rev 1987; 67: 111742.
  • 24
    Maggio JE. Tachykinins. Annu Rev Neurosci 1988; 11: 1328.
  • 25
    Erspamer V. The tachykinin peptide family. Trends Neurosci 1981; 4: 2679.
  • 26
    Teichberg VI, Cohen S & Blumberg S. Distinct classes of substance P receptors revealed by a comparison of the activities of substance P and some of its segments. Regul Pept 1981; 1: 32733.
  • 27
    Lee C-M, Iversen LL, Hanley MR & Sandberg BEB. The possible existence of multiple receptors for substance P. Naunyn-Schmiedeberg's Arch Pharmacol 1982; 318: 2817.
  • 28
    Buck SH & Burcher E. The tachykinins: a family of peptides with a brood of ‘receptors’. Trends Pharmacol Sci 1986; 7: 658.
  • 29
    Regoli D, Drapeau G, Dion S & D'orleans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci 1987; 40: 10917.
  • 30
    Maggi CA, Giuliani S, Santicioli P, Regoli D & Meli A. Peripheral effect of neurokinins: functional evidence for the existence of multiple receptors. J Autonom Pharmacol 1987; 7: 1132.
  • 31
    Masu Y, Nakayama K, Tamaki H, Harada Y, Kuno M & Nakanishi S. cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 1987; 329: 8368.
  • 32
    Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci 1991; 14: 12336.
  • 33
    Betancur C, Azzi M & Rostène W. Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Physiol Sci 1997; 18: 37286.
  • 34
    Folkers K, Hörig J, Rosell S & Björkroth U. Chemical design of antagonists of substance P. Acta Physiol Scand 1981; 111: 5056.
  • 35
    Håkanson R & Sundler F. Tachykinin Antagonists. Fernström Foundation Series. Amsterdam, Netherlands: Elsevier, 1985.
  • 36
    Snider RM, Constantine JW & Lowe IJ et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 1991; 251: 4357.
  • 37
    Gether U, Johansen TE, Snider RM, Lowe AJ, Nakanishi S & Schwartz TW. Different binding epitope for substance P and the non-peptide antagonist, CP-96,345, on the NK1 receptor. Nature 1993; 362: 3458.
  • 38
    Holst B, Zoffman S, Elling CE, Hjorth SA & Schwartz TW. Steric hindrance mutagenesis versus ALA-scan in mapping of ligand binding sites in the tachykinin NK1 receptor. Mol Pharm 1998; 53: 16675.
  • 39
    Maggi CA. Principles of tachykinergic co-transmission in the peripheral and enteric nervous system. Reg Pep 2000 (in press).
  • 40
    Holzer P & Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 1997; 73: 21963.DOI: 10.1016/s0163-7258(96)00196-9
  • 41
    Holzer P & Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther 1997; 73: 173217.DOI: 10.1016/s0163-7258(96)00195-7
  • 42
    Furness JB & Costa M. The Enteric Nervous System. New York: Churchill Livingstone, 1987.
  • 43
    Oku R, Satoh M & Takagi H. Release of substance P from the spinal dorsal horn in enhanced in polyarthritic rats. Neurosci Lett 1987; 74: 3159.
  • 44
    Schaible H-G, Jarrott B, Hope PJ & Duggan AW. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res 1990; 529: 21423.
  • 45
    Duggan AW, Hendry IA, Morton CR, Hutchinson WD & Zhao ZQ. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 1988; 451: 26173.
  • 46
    Krause JE, DiMaggio DA & McCarson KE. Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation. Can J Physiol Pharmacol 1995; 73: 8549.
  • 47
    Radhakrishnan V & Henry JL. Novel substance P antagonist, CP-99,345, blocks responses of cat spinal dorsal horn neurones to noxious cutaneous stimulation and to substance P. Neurosci Lett 1991; 132: 3943.
  • 48
    Thompson SWN, Dray A & Urban L. Injury-induced plasticity of spinal reflex activity: NK-1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in rat spinal cord in vitro. J Neurosci 1994; 14: 367287.
  • 49
    Radhakrishnan V, Iyengar S & Henry JL. The nonpeptide NK-1 receptor antagonists LY-303,870 and LY-306,740 block the responses of spinal dorsal horn neurons to substance P and to peripheral noxious stimuli. Neurosci 1998; 83: 125160.
  • 50
    Dalsgaard C-J, Haegerstrand A, Theodorsson-Norheim E, Brodin E & Hökfelt T. Neurokinin-A like immunoreactivity in rat primary sensory neurons: coexistence with substance P. Histochemistry 1985; 83: 3740.
  • 51
    Fleetwood-Walker SM, Mitchell R, Hope PJ, El-Yassir N, Molony V & Bladon CM. The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat. Brain Res 1990; 519: 16982.
  • 52
    Xu X-J & Wiesenfeld-Hallin Z. Intrathecal neurokinin A facilitates the spinal nociceptive flexor reflex evoked by thermal and mechanical stimuli and synergistically interacts with substance P. Acta Physiol Scand 1992; 144: 1638.
  • 53
    Wiesenfeld-Hallin Z & Xu X-J. The differential role of substance P and neurokinin A in spinal cord hyperexcitability and neurogenic inflammation. Regul Peptides 1993; 46: 16573.
  • 54
    Xu X-J, Dalsgaard C-J & Wiesenfeld-Hallin Z. Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation. Eurp J Pharmacol 1992; 216: 33744.
  • 55
    Xu X-J, Maggi CA & Wiesenfeld-Hallin Z. On the role of the NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat. Neurosci 1991; 44: 48390.
  • 56
    Ma OP & Woolf CJ. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurons. J Physiol 1995; 486: 76977.
  • 57
    Rosenfeld MG, Mermod JJ & Amara SG et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Proc Natl Acad F Sci USA 1983; 304: 12935.
  • 58
    Gibson SJ, Polak JM & Bloom SR et al. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and eight other species. J Neurosci 1984; 4: 310111.
  • 59
    Wiesenfeld-Hallin Z, Hökfelt T & Lundberg JM et al. Immunoreactive calcitonin gene-related peptide and substance P co-exist in sensory neurons to the spinal cord and interact in spinal behavioural responses of the rat. Neurosci Lett 1984; 52: 199204.
  • 60
    Piercey MF, Dobry PJ, Schroeder LA & Einspahr FJ. Behavioural evidence that substance P may be a spinal cord sensory neurotransmitter. Brain Res 1981; 210: 40712.
  • 61
    Ch'ng JLC, Christofides ND & Anand P et al. Distribution of galanin immunoreactivity in the central nervous system and responses of galanin-containing neuronal pathways to injury. Neurosci 1985; 16: 34354.
  • 62
    Skofitsch G & Jacobowitz DM. Galanin-like immunoreactivity in capsaicin sensitive sensory neurons and ganglia. Brain Res Bull 1985; 15: 1915.
  • 63
    Hökfelt T, Wiesenfeld-Hallin Z, Villar MJ & Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett 1987; 83: 21720.
  • 64
    Wiesenfeld-Hallin Z, Bartfai T & Hökfelt T. Galanin in sensory neurons in the spinal cord. Front Neuroendocrinol 1992; 13: 31943.
  • 65
    De Biasi S & Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 1988; 85: 78204.
  • 66
    Davies SN & Lodge D. Evidence for involvement of N-methylaspartate receptors in ‘wind-up’ of class 2 neurons in the dorsal horn of the rat. Brain Res 1987; 424: 4026.
  • 67
    Woolf CJ & Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293300.
  • 68
    Xu X-J, Dalsgaard C-J & Wiesenfeld-Hallin Z. Spinal substance P and N-methyl-d-aspartate receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex. Neurosci 1992; 44: 48390.
  • 69
    Urban L, Thompson SW & Dray A. Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci 1994; 17: 4328.
  • 70
    Van Dongen PAM, Hökfelt T & Grillner S et al. Immunohistochemical demonstration of some putative neurotransmitters in the lamprey spinal cord and spinal ganglia: 5-hydroxytryptamine-, tachykinin-, and neuropeptide Y-immunoreactive neurons and fibers. J Comp Neurol 1985; 234: 50122.
  • 71
    Scotland J, Shupliakov O & Wikström M et al. Control of lamprey locomotor neurons by colocalized monoamine transmitters. Nature 1995; 374: 2668.
  • 72
    Grillner S, Ekeberg Ö & El Manira A et al. Intrinsic function of a neuronal network: a vertebrate central pattern. Brain Res Rev 1998; 26: 18477.
  • 73
    Parker D & Grillner S. Cellular and synaptic modulation underlying substance P-mediated plasticity of the lamprey locomotor network. J Neurosci 1998; 18: 8095110.
  • 74
    Parker D, Zhang W & Grillner S. Substance P modulates NMDA responses and causes long-term protein synthesis-dependent modulation of the lamprey locomotor network. J Neurosci 1998; 18: 480013.
  • 75
    Parker D & Grillner S. Activity-dependent metaplasticity of inhibitory and excitatory synaptic transmission in the lamprey spinal cord locomotor network. J Neurosci 1999; 19: 164756.
  • 76
    Parker D & Grillner S. Long-lasting substance-P-mediated modulation of NMDA-induced rhythmic activity in the lamprey locomotor network involves separate RNA- and protein-synthesis-dependent stages. Eur J Neurosci 1999; 11: 151522.DOI: 10.1046/j.1460-9568.1999.00565.x
  • 77
    De Felipe C, Herrero JF & O'brian JA et al. Nociception, analgesia and aggression are disrupted in mice lacking the substance P receptor. Nature 1998; 392: 3947.DOI: 10.1038/32904
  • 78
    Cao YQ, Manthy PW, Carlson EJ, Gillespie A-M, Epstein CJ & Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998; 392: 3904.DOI: 10.1038/32897
  • 79
    Zimmer A, Zimmer AM & Baffi J et al. Hypoalgesia in mice with a targeted deletion of the tachkinin 1 gene. Proc Nat Acad Sci USA 1998; 95: 26305.
  • 80
    Ahluwalia A, De Felipe C, O'brian J, Hunt SP & Perretti M. Impaired IL-1-1-induced neurtrophil accumulation in tachykinin NK1 receptor knockout mice. Brit J Pharm 1998; 124: 10135.
  • 81
    Laird JMA, Olivar T, Roza C, De Felipe C & Cervero F. Visceral hyperalgesia and acute responses to chemical but not mechanical visceral stimuli are abolished in NK1 receptor knockout mice. Soc Neurosci Abstract 1998; 24: 881.
  • 82
    Mansikka H, Shiotani M, Winchurch R & Raja SN. Neurokinin-1 receptors are involved in bahavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice. Anesthesiol 1999; 90: 16439.
  • 83
    Mantyh PW, Demaster E & Malhotra A et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995; 268: 162932.
  • 84
    Abbadie C, Brown JL, Mantyh PW & Basbaum AI. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neurosci 1996; 70: 2019.
  • 85
    Abbadie C, Trafton J, Liu H, Mantyh PW & Basbaum AI. Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. J Neurosci 1997; 17: 804960.
  • 86
    Mantyh PW, Rogers SD & Honore P et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997; 278: 2759.DOI: 10.1126/science.278.5336.275
  • 87
    Nichols ML, Allen BJ & Rogers SD et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999; 286: 155861.DOI: 10.1126/science.286.5444.1558
  • 88
    Kramer MS, Cutler N & Feighner J et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998; 281: 16405.
  • 89
    Rupniak NM, Carlson EC & Harrison T et al. Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalization in guinea-pigs and mice. Neuropharmacol 2000; 39: 141321.
  • 90
    Baker KG, Halliday GM, Hornung JP, Geffen LB, Cotton RG & Törk I. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neurosci 1991; 42: 75775.
  • 91
    Sergeyev V, Hökfelt T & Hurd Y. Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. Neuroreport 1999; 10: 396770.
  • 92
    Rupniak NM & Kramer MS. Discovery of the antidepressant and anit-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999; 20: 48590.DOI: 10.1016/s0165-6147(99)01396-6
  • 93
    Rudd JA & Naylor RJ. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. Br J Pharmacol 1996; 118: 20914.
  • 94
    Nilsson J, Von Euler A & Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985; 315: 613.
  • 95
    De Felipe C, Pinnock RD & Hunt SP. Modulation of chemotropism in the developing spinal cord by substance P. Science 1995; 267: 899902.
  • 96
    Strand FL, Rose KJ, Zuccarelli LA & Kume J. Neuropeptide hormones as neurotrophic factors. Physiol Review 1991; 71: 101737.
  • 97
    Schwartz J. Neurotransmitters as neurotrophic factors: a new set of functions. Int Rev Neurobiol 1990; 34: 123.
  • 98
    Holst B, Elling CE & Schwartz TW. Partial agonism through a zinc-ion switch constructed between TM-III and TM-VII in the tachykinin NK1 receptor. Mol Pharmacol 2000; 58: 26370.